AI assistant
Sending…
INTUITIVE SURGICAL INC — Director's Dealing 2019
Feb 7, 2019
29809_dirs_2019-02-06_eebda227-74da-4efe-bf3b-131d41e2dd1a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2019-02-06
Reporting Person: Andersen Reiter Kara (Sr VP General Counsel & CCO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3309 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $170.7567 | 2025-02-06 | Common Stock (9000) | Direct | |
| Non-Qualified Stock Option (right to buy) | $178.3867 | 2026-02-16 | Common Stock (1500) | Direct | |
| Non-Qualified Stock Option (right to buy) | $230.9967 | 2026-08-15 | Common Stock (1500) | Direct | |
| Non-Qualified Stock Option (right to buy) | $238.9133 | 2027-02-15 | Common Stock (1350) | Direct | |
| Non-Qualified Stock Option (right to buy) | $328.4567 | 2027-08-15 | Common Stock (1350) | Direct | |
| Non-Qualified Stock Option (right to buy) | $418.56 | 2028-02-15 | Common Stock (875) | Direct | |
| Non-Qualified Stock Option (right to buy) | $522.77 | 2028-08-15 | Common Stock (875) | Direct |
Footnotes
F1: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F2: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter.
More from INTUITIVE SURGICAL INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3